Davis S, Boone C W
J Natl Cancer Inst. 1975 Feb;54(2):435-8.
The effects of in vivo-administered concanavalin A (Con A) on the kinetics of the primary and secondary cellular immune responses to simian virus 40-transformed tumor cells were investigated in BALB/c mice. Either a single initial dose of 400 mug Con A or daily doses of 50 mug depressed the cell-mediated immune response to tumor cells during the progressive growth of tumors, as determined by a radioisotopic foot-pad assay. The immune depression correlated with an increase in ultimate tumor weight. Similarly, Con A suppressed the antitumor cellular immune response in tumor-immune animals. Immune reactivity returned within 6 days after a single injection of 400 mug Con. Continuous administration 50 mug Con A resulted in a gradual decline in antitumor cellular immune responsiveness, which reached a plateau by the 5th day. Splenic lymphocytes from Con A-treated, immune mice failed to elicit a local adoptive transfer reaction; their immune responsiveness tended to return after incubation with alpha-methyl-D-pyranosyl sugars.
在BALB/c小鼠中研究了体内注射伴刀豆球蛋白A(Con A)对针对猿猴病毒40转化肿瘤细胞的初次和二次细胞免疫反应动力学的影响。通过放射性同位素足垫试验确定,在肿瘤进行性生长期间,单次初始剂量400μg Con A或每日剂量50μg均会抑制对肿瘤细胞的细胞介导免疫反应。免疫抑制与最终肿瘤重量的增加相关。同样,Con A抑制了肿瘤免疫动物中的抗肿瘤细胞免疫反应。单次注射400μg Con后,免疫反应性在6天内恢复。连续给予50μg Con A导致抗肿瘤细胞免疫反应性逐渐下降,到第5天达到平台期。来自Con A处理的免疫小鼠的脾淋巴细胞未能引发局部过继转移反应;与α-甲基-D-吡喃糖基糖孵育后,它们的免疫反应性倾向于恢复。